🇺🇸 FDA
Patent

US 11944658

Methods of heat inactivation of adenovirus

granted A61KA61K35/761

Quick answer

US patent 11944658 (Methods of heat inactivation of adenovirus) held by Ultragenyx Pharmaceutical Inc. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/761